Clascoterone cream for moderate to severe acne
Part of Skin clinical trials.
This trial tests a cream called clascoterone (1%) for people ages 12 and up with moderate to severe facial acne. The cream is applied daily to help reduce pimples and clogged pores.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 12 years old.
- You have moderate to severe acne on your face, with 30–75 red bumps or pus-filled pimples and 30–100 blackheads or whiteheads.
- You have used the same brand of skin and hair products for at least 2 weeks and agree to keep using them during the study.
- You and your partner must use effective birth control during the study and for 3 months after the last dose, and you cannot plan to get pregnant or donate sperm or eggs.
- You do not have more than 2 deep, painful bumps (nodules) or any cysts on your face.
- You have not used certain acne treatments or anti-acne skin products within 2 weeks before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
This trial tests a new acne cream called clascoterone compared to a standard cream, adapalene, for mild acne. It aims to see which one works better for clearing pimples.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
This trial tests a cream called KR230109 for mild to moderate facial acne. It aims to see if the cream is safe and works well. You may qualify if you are 18 to 40 and have at least 10 pimples and 20 blackheads or whiteheads on your face, but no deep cysts.
This study tests a new acne treatment called Cabtreo in children and young teens ages 9–11. The treatment combines three ingredients to reduce acne bumps and spots on the face and body.
This trial tests a new medicine, HB0043, to see if it helps adults with moderate to severe facial acne. You cannot use other acne treatments during the study.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.